<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 27, 1997
U.S. MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
TEXAS 74-2599718
(State of incorporation) (IRS Employer Identification No.)
1-12954
(Commission File Number)
12201 Technology Boulevard, Suite 100, Austin, Texas
(Address of principal executive offices)
Registrant's telephone number: (512) 257-8787
This document consists of 3 pages of which this is page 1.
<PAGE>
Item 1. Changes in Control of Registrant
None
Item 2. Acquisition or Disposition of Assets
None
Item 3. Bankruptcy or Receivership
Not applicable
Item 4. Changes in Registrant's Certifying Accountants
None
Item 5. Other Events
US Medical Products, Inc. ("USMP") (BSE-UMP, USMD, USMD/U, USMD/W),
located at 12201 Technology Blvd., Austin, Texas, has entered into
negotiations to sell a majority of its assets to Hayes Medical, Inc.
(Sacramento, California). These assets include implant and instrument
inventories, property and equipment, patents and regulatory approvals.
In addition to the assumption of certain liabilities, Hayes Medical
will pay USMP using a combination of cash, royalties and a secured
note.
At the same time, USMP has entered into merger negotiations with
Metrax Medical, Inc. (Delaware Corporation), Metrax Medical, Inc. is
a privately held company that develops, manufactures and
internationally distributes professional medical products and consumer
wellness products. Metrax Medical Inc. owns 100% of Metrax GmbH, a 24
year old German based medical products company with annual sales of
over $16 million. Metrax Medical Inc. also owns approximately 80% of
the outstanding common stock of USMP.
Item 6. Resignations of Registrant's Directors
None
Item 7. Financial Statements and Exhibits
None
Item 8. Changes in Fiscal Year
Not Applicable
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
U.S. Medical Products, Inc.
Registrant
/s/ Fred Mindermann
---------------------------------
Fred Mindermann
Acting Chief Executive Officer
3
